Index of HIV/AIDS-related articles

(Redirected from List of AIDS-related topics)

This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition. [1]


AACTGacquired immunityacquired immunodeficiency syndrome (AIDS) – ACT UP/Golden Gateactive immunityacupunctureacute HIV infectionAcute HIV Infection and Early Diseases Research Program (AIEDRP) – ADAPADCadenopathyadherenceadjuvantadministrationAdult AIDS Clinical Trials Group (AACTG) – adverse drug reactionaerosolizedAETCagammaglobulinemiaAgency for Healthcare Research and Quality (AHRQ) – AHRQAIDSAIDS ArmsAIDS dementia complex (ADC) – AIDS Drug Assistance Programs (ADAP) – AIDS education and training centers (AETC) – AIDS orphanAIDS research advisory committee (ARAC) – AIDS service organization (ASO) – The AIDS ShowAIDS Vaccine 200AIDS Vaccine Advocacy CoalitionAIDS wasting syndromeAIDS-related cancerAIDS-related complex (ARC) – alkaline phosphatasealopeciaalpha interferon (INFa) – alternative medicinealveolaramebiasisamino acidsanaphylactic shockanemiaanergyangiogenesisangiomatosisanorexiaantenatalantibioticantibodiesantibody-dependent cell-mediated cytotoxicity (ADCC) – antibody-mediated immunityantifungal medicationantigenantigen presentationantigen-presenting cell (APC) – antineoplasticantiprotozoalantiretroviral drugsantisense drugsantitoxinsAntiviral drugaphasiaaphthous ulcerapoptosisapproved drugsARCArmenicumARTarthralgiaASOaspergillosisassembly and buddingasymptomaticataxiaattenuatedautoantibodyautoimmunizationautoinoculationautologousavascular necrosis (AVN) – AVN

B-cell lymphomaB cellsB lymphocytes (B cells) – bactericidalbacteriostaticbacteriumbaculovirusbaselinebasophilbDNA testbeta-2 microglobulin (β2M) – bilirubinbioavailabilitybiological response modifiers (BRMs) – biopsybiotechnologyblinded study – blips – blood–brain barrierbody fat redistribution (BFR) syndromebody fluidsbone marrowbone marrow suppressionboosterbranched DNA assaybreakthrough infectionBroadway Cares/Equity Fights AIDSbronchoscopybuddingbuffalo humpbugchasing and giftgivingBurkitt's lymphoma

C-T scan (computed tomography scan) – cachexiaCanadian Foundation for AIDS ResearchcandidacandidiasiscarcinogenCAT scanCCR5CD4 (T4) or CD4 + cellsCDC National Prevention Information Network (CDC-NPIN) – cell linescell-mediated immunity (CMI) – cellular immunityCenters for Disease Control and Prevention (CDC) – Centers for Medicare and Medicaid Services (CMS) – central nervous systemcerebrumcerebrospinal fluid (CSF) – cervical cancercervical dysplasiacervical intraepithelial neoplasia (CIN1, CIN2, CIN3) – cervixchancroidchemokineschemoprophylaxischemotherapyChlamydiachronic idiopathic demyelinating polyneuropathy (CIPD) – circumoral paresthesiacladeclinical endpointclinical latencyclinical practice guidelinesclinical trialclinicaltrials.govcloningCMSCMVCNSco-receptorscoccidioidomycosiscodoncofactorscognitive impairmentcohortcolitiscombination therapycommunity planningCommunity Programs for Clinical Research on AIDS (CPCRA) – community-based clinical trial (CBCT) – community-based organization (CBO) – compassionate usecomplementcomplement cascadecomplementary and alternative therapycomplete blood count (CBC) – computed tomography scan (C-T scan) – concomitant drugscondylomacondyloma acuminatumcontagiouscontraindicationcontrolled trialscorecore proteincorrelates of immunity/correlates of protectioncreatininecross-resistancecryotherapycryptococcal meningitiscryptococcosisCryptococcus neoformanscryptosporidiosisCryptosporidiumCSFCTLcutaneousCXCR4cytokinescytomegalovirus (CMV) – Cytomegalovirus retinitiscytopeniacytotoxiccytotoxic T lymphocyte (CTL)

DAIDSdata safety and monitoring board (DSMB) – deletiondementiademyelinationdendritedendritic cellsdeoxyribonucleic acid (DNA) – Department of Health and Human Services (DHHS/HHS or DHHS) – desensitizationdiabetes mellitus (DM) – diagnosisdiarrheadiplopiadisseminationdivision of acquired immunodeficiency syndrome (DAIDS) – DNADomain (biology)dose-ranging studydose-response relationshipdouble-blind studydrug resistancedrug-drug interactionDSMBDuffy antigen systemdysplasiadyspnea

efficacyempiricalencephalitisend-stage disease – endemic – endogenousendoscopyendotoxinendpointentericenteritisentry inhibitorsEnvenvelopeenzymeenzyme-linked immunosorbent assay (ELISA) – eosinophileosinophilic folliculitisepidemicepidemiological surveillanceepidemiologyepitheliumepitopeEpstein-Barr virus (EBV) – erythemaerythema multiformeerythrocytesetiologyexogenousexotoxinexpanded accessexperimental drugexpression system

fat redistributionFDA FDCfloatersfolliclefollicular dendritic cells (FDCs) – Food and Drug Administration (United States) functional antibodyfungusfusinfusion inhibitorfusion mechanismfusion peptide

GAGgamma globulingamma interferonganglionGARTgastrointestinal (GI) – genegene therapygenetic engineeringgenital ulcer diseasegenital wartsgenitourinary tractgenomegenotypic assaygerminal centersgiardiasisglobulinsglycoproteingonorrheagp120 (gp120) – gp160 (gp160) – gp41 (gp41) – granulocytegranulocyte macrophage-colony stimulating factor (GM-CSF) – granulocyte-colony stimulating factor (G-CSF) – granulocytopenia

HAARThairy leukoplakiahalf-lifeHAM/TSPHealth Care Financing Administration (HCFA) – Health Resources and Services Administration (HRSA) – HELLP syndromehelper T cellshelper/suppressor ratio (of T cells) – hematocrithematotoxichemoglobinhemolysishemophiliahepatichepatic steatosishepatitishepatitis C and HIV coinfectionhepatomegalyherpes simplex virus 1 (HSV-1) – herpes simplex virus 2 (HSV-2) – herpes varicella zoster virus (VZV) – herpes viruseshighly active antiretroviral therapy (HAART) – histocompatibility testinghistoplasmosisHIV diseaseHIV prevention trials network (HPTN) – HIV set pointHIV vaccine trials network (HVTN) – HIV-1HIV-2HIV-associated dementiaHIV-related tuberculosisHLAHodgkin's diseaseholistic medicinehomology (biology)hormonehosthost factorsHPTNHPVHRSAHTLV-IHTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) – HTLV-IIhuman growth hormone (HGH) – human immunodeficiency virus type 1 (HIV-1) – human immunodeficiency virus type 2 (HIV-2) – human leukocyte antigens (HLA) – human papilloma virus (HPV) – human T cell lymphotropic virus type I (HTLV-I) – human T cell lymphotropic virus type II (HTLV-II) – humoral immunityHVTNhydroxyureahypergammaglobulinemiahyperglycemiahyperlipidemiahyperplasiahyperthermiahypogonadismhypothesishypoxia

idiopathicidiopathic thrombocytopenia purpuraIHSimmune compleximmune deficiency/immunodeficiencyimmune responseimmune systemimmune thrombocytopenic purpuraimmunityimmunizationimmunocompetentimmunocompromisedimmunodeficiencyimmunogenimmunogenicityimmunoglobulin (Ig) – immunoglobulin A (IgA) – immunoglobulin D (IGD) – immunoglobulin E (IGE) – immunoglobulin G (IGG) – immunoglobulin M (IGM) – immunomodulatorimmunostimulantimmunosuppressionimmunotherapyimmunotoxinin vitroin vivoincidenceIncubation periodINDIndian Health Service (IHS) – infectioninfectiousinformed consentinfusioninoculationinstitutional review board (IRB) – integraseintegrase inhibitorsInteractioninterferoninterleukin-1 (IL-1) – interleukin-2 (IL-2) – interleukin-4 (IL-4) – interleukin-12 (IL-12) – interleukinsInternational Center for Research on Womenintramuscular (IM) – intravenousintravenous immunoglobulin (IVIG) – intravitrealInvestigational New Drug (IND) – IRBITPIVIG

jaundiceJC virus

Kaposi's sarcoma (KS) – Karnofsky scorekiller T cellsKSHVKupffer cells

Langerhans cellsLASlentiviruslesionleukocytesleukocytosisleukopenialeukoplakiaLFTLIPlipidlipodystrophyliposomeslive vector vaccineliver function test (LFT) – long terminal repeat sequence (LTR) – long-term nonprogressorsLTRlumbarlumbar puncturelymphlymph nodeslymphadenopathy syndrome (LAS) – lymphatic vesselslymphocytelymphoid interstitial pneumonitis (LIP) – lymphoid organslymphoid tissuelymphokine-activated killer cells (LAK) – lymphokineslymphomalymphopenialymphoproliferative responselysis

MACmacrophagemacrophage-tropic virusmagnetic resonance imaging (MRI) – MAImaintenance therapymajor histocompatibility complex (MHC) – malabsorption syndromemalaisemalignantmast cellMedlinePlusmega-HAARTmemory T cellsmeningesmeningitismessenger RNAmetabolismmetastasisMHCmicrobesmicrobicideMicrosporidiosismitochondriamitochondrial toxicitymoleculemolluscum contagiosummonocytemononeuritis multiplex (MM) – monovalent vaccinemorbidityMRImucocutaneousmucosamucosal immunitymucous membraneMulticenter AIDS Cohort Studymulti-drug rescue therapymultiple drug-resistant tuberculosis (MDR-TB) – mutationmyalgiamycobacteriummycobacterium avium complex (MAC) – mycosismyelinmyelopathymyelosuppressionmyelotoxicmyocardialmyopathy

NATNational Cancer Institute (NCI) – National Institute of Allergy and Infectious Diseases (NIAID) – National Institute of Child Health and Human Development (NICHD) – National Institutes of Health (NIH) – National Library of Medicine (NLM) – National Prevention Information Network (NPIN) – natural history studynatural killer cells (NK cells) – NCINew Drug ApplicationnebulizedNefneoplasmnephrotoxicneuralgianeurological complications of AIDSneuropathyneutralizationneutralizing antibodyneutralizing domainneutropenianeutrophilNew Drug Application (NDA) – New York CaresNIAIDNICHDnight sweatNIHNK cellNLMNNRTInon-Hodgkin's lymphoma (NHL) – non-nucleoside reverse transcriptase inhibitors (NNRTI) – non-steroidal anti-inflammatory drugs (NSAID) – NRTInucleic acidnucleic acid testnucleocapsidnucleolinucleosidenucleoside analognucleoside reverse transcriptase inhibitors (NRTI) – nucleotidenucleotide analogsnucleusnull cell

ocularoff-label useoncologyopen-label trialopportunistic infectionsoral hairy leukoplakia (OHL) – organelleoropharyngealorphan drugsosteonecrosisosteopenia

P24package insertpalliativepalliative carepancreaspancreatitispancytopeniapandemicpap smearpapillomaparallel trackparasiteparenteralparesthesiapassive immunitypassive immunotherapypathogenpathogenesisPBMCPCPPCRPediatric AIDS Clinical Trial Group (PACTG) – pelvic inflammatory diseasepeptideperianalperinatalperinatal transmissionperipheral neuritisperipheral neuropathypersistent generalized lymphadenopathyPGLphagocytephagocytosispharmacokineticsphase I trialsphase II trialsphase III trialsphase IV trialsphotosensitivityPHSpituitary glandplaceboplacebo controlled studyplacebo effectplasmaplasma cellsplateletsPMLPneumocystis jiroveci pneumonia (formerly Pneumocystis carinii or PCP) – POLpolymerasepolymerase chain reaction (PCR)polyneuritispolypeptidepolyvalent vaccinepost-exposure prophylaxis (PEP) – PPD testpre-conception counselingpreclinicalprecursor cellsprevalenceprimary HIV infectionprimary isolateprimaquineproctitisprodromeprodrugprogressive multifocal leukoencephalopathy (PML) – prophylactic drugprophylaxisproteaseprotease inhibitorsprotease-sparing regimenproteinsprotocolprotozoaprovirusprurituspseudo-Cushing's syndromepseudovirionPUBMEDpulmonarypurified protein derivative (PPD)

radiologyrandomized trialreboundreceptor (immunology)recombinantrecombinant DNArecombinant DNA technologyregulatory genesregulatory T cellsremissionrenalrescue therapyresistanceretinaretinal detachmentretinitisretrovirusREVreverse transcriptaseribonucleic acid (RNA) – ribosomeRNAroute of administrationRT-PCRRTIRyan White C.A.R.E. act

safe sexsafer sexsalmonellasalvage therapySAMHSAsarcomaseborrheic dermatitissecondary prophylaxissepsisseroconversionserologic testseroprevalenceserosortingserostatusserumserum glutamic oxaloacetic transaminase (SGOT) – serum glutamic pyruvate transaminase (SGPT) – sexually transmitted disease (STD) – shinglesSHIVside effectssimian immunodeficiency virus (SIV) – sinusitissocial integration SITSIVSpecial Projects of National Significance (SPNS) – spinal tapspleensplenomegalysputum analysisstandard of carestaphylococcusSTDstem cells (FDCs) – steroidStevens–Johnson syndromeSTIstomatitisstrainstratificationstructured intermittent therapy (SIT) – structured treatment interruption (STI) – study endpointsubarachnoid spacesubclinical infectionsubcutaneous (SQ) – Substance Abuse and Mental Health Services Administration (SAMHSA) – subunit HIV vaccinesulfa drugsulfonamidessuperantigensuppressor T cellsurrogate markersurveillancesusceptiblesymptomssyncytiumsyndromesynergysynergisticsynthesissyphilissystemic

T cells (T lymphocytes) – T lymphocyte proliferation assayT lymphocytesT suppressor cellsT4 cells (T-helper cells) – T8 cellsTanner stagingTATTBtemplateTeachAidsteratogenicitytestosteronetherapeutic HIV vaccinethrombocytopeniathrushthymosinthymustissuetitertoxicitytoxoplasmic encephalitistoxoplasmosistransaminasetranscriptiontransfusiontranslationtransmissiontransplacentaltreatment INDtriglyceridestuberculin skin test (TST) – tuberculosis (TB) – tumor necrosis factor (TNF)

V3 loopvaccinationvaccinevacciniavaginal candidiasisvalley fevervariable regionvaricella zoster virus (VZV) – vectorvertical transmissionviral burdenviral coreviral cultureviral envelopeviral loadviremiaviricidevirionvirologyvirusvisceral

wasting syndromeWestern blotwhite blood cellswild-type viruswindow periodWomen's Interagency HIV Study (WIHS) – World AIDS DayWorld AIDS Vaccine Day

yeast infectionYouth Against AIDS

zinc finger inhibitorzinc fingers